{
  "actions": [
    {
      "acted_at": "2024-10-11",
      "action_code": "Intro-H",
      "references": [],
      "text": "Introduced in House",
      "type": "action"
    },
    {
      "acted_at": "2024-10-11",
      "action_code": "H11100",
      "committees": [
        "HSIF"
      ],
      "references": [],
      "status": "REFERRED",
      "text": "Referred to the House Committee on Energy and Commerce.",
      "type": "referral"
    }
  ],
  "amendments": [],
  "bill_id": "hr9979-118",
  "bill_type": "hr",
  "by_request": false,
  "committee_reports": [],
  "committees": [
    {
      "activity": [
        "Referred To"
      ],
      "committee": "House Energy and Commerce",
      "committee_id": "HSIF"
    }
  ],
  "congress": "118",
  "cosponsors": [
    {
      "bioguide_id": "B001257",
      "district": "12",
      "name": "Bilirakis, Gus M.",
      "original_cosponsor": true,
      "sponsored_at": "2024-10-11",
      "state": "FL",
      "title": "Rep.",
      "withdrawn_at": null
    },
    {
      "bioguide_id": "D000230",
      "district": "1",
      "name": "Davis, Donald G.",
      "original_cosponsor": false,
      "sponsored_at": "2024-11-15",
      "state": "NC",
      "title": "Rep.",
      "withdrawn_at": null
    }
  ],
  "enacted_as": null,
  "history": {
    "active": false,
    "awaiting_signature": false,
    "enacted": false,
    "vetoed": false
  },
  "introduced_at": "2024-10-11",
  "number": "9979",
  "official_title": "To amend the Federal Food, Drug, and Cosmetic Act to establish a process for externally led, science-focused drug development meetings, and for other purposes.",
  "popular_title": null,
  "related_bills": [],
  "short_title": "Scientific EXPERT Act of 2024",
  "sponsor": {
    "bioguide_id": "M001163",
    "district": "7",
    "name": "Matsui, Doris O.",
    "state": "CA",
    "title": "Rep.",
    "type": "person"
  },
  "status": "REFERRED",
  "status_at": "2024-10-11",
  "subjects": [
    "Advisory bodies",
    "Congressional oversight",
    "Drug safety, medical device, and laboratory regulation",
    "Government information and archives",
    "Health",
    "Medical research",
    "Research administration and funding"
  ],
  "subjects_top_term": "Health",
  "summary": null,
  "titles": [
    {
      "as": null,
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "Scientific EXPERT Act of 2024",
      "type": "display"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "Scientific EXPERT Act of 2024",
      "type": "short"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "Scientific External Process for Educated Review of Therapeutics Act of 2024",
      "type": "short"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "To amend the Federal Food, Drug, and Cosmetic Act to establish a process for externally led, science-focused drug development meetings, and for other purposes.",
      "type": "official"
    }
  ],
  "updated_at": "2025-08-14T18:24:46Z",
  "url": "https://www.govinfo.gov/bulkdata/BILLSTATUS/118/hr/BILLSTATUS-118hr9979.xml"
}